2023
Home-based cardio-oncology rehabilitation using a telerehabilitation platform in hematological cancer survivors: a feasibility study
FILAKOVA, Katerina, Andrea JANÍKOVÁ, Marián FELŠŐCI, Filip DOSBABA, Jing Jing SU et. al.Základní údaje
Originální název
Home-based cardio-oncology rehabilitation using a telerehabilitation platform in hematological cancer survivors: a feasibility study
Autoři
FILAKOVA, Katerina (203 Česká republika), Andrea JANÍKOVÁ (203 Česká republika), Marián FELŠŐCI (703 Slovensko), Filip DOSBABA (203 Česká republika), Jing Jing SU, Garyfallia PEPERA a Ladislav BAŤALÍK (203 Česká republika, garant, domácí)
Vydání
BMC SPORTS SCIENCE MEDICINE AND REHABILITATION, LONDON, BMC, 2023, 2052-1847
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30304 Public and environmental health
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.900 v roce 2022
Kód RIV
RIV/00216224:14110/23:00130650
Organizační jednotka
Lékařská fakulta
UT WoS
000953040300002
Klíčová slova anglicky
Cardio-oncology rehabilitation; Telerehabilitation; Home-based exercise; Cardiorespiratory fitness; Telemonitoring
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 31. 1. 2024 13:26, Mgr. Tereza Miškechová
Anotace
V originále
PurposeCardiovascular disease is a competing mortality cause in hematological cancer survivors due to toxic oncological treatment, accumulation of risk factors, and decline of cardiorespiratory fitness. Cardio-oncology rehabilitation (CORE) is an emerging treatment model to optimize the prognosis of hematological cancer patients and survivors; however, its accessibility during the COVID-19 pandemic is poor. The study aimed to evaluate the feasibility, safety, and effect of a 12-week home-based CORE intervention in telerehabilitation approach among hematological cancer survivors.MethodsA prospective single-arm interventional study was conducted at a faculty hospital in Brno, Czech Republic. This study provided 12 weeks of the home-based CORE using a telerehabilitation approach that allows remote supervision by a clinician from a medical facility. The telerehabilitation approach consists of three components: a heart rate sensor (PolarM430, Kempele, Finland), a web platform compatible with the sensor, and telesupervising via telephone call (1 call per week). To improve adherence, a physiotherapist called participants to assess or address adverse effects, exercise feedback, and participant-related concerns. The anthropometry, body composition, and cardiorespiratory fitness were measured immediately after the intervention.ResultsEleven hematological cancer survivors with an average age of 60.3 +/- 10 years participated in the study. Most participants were diagnosed with Follicular lymphoma and received maintenance treatment. Participants had a significant (p < 0.05) increase in cardiorespiratory fitness by 2.6 ml/kg/min; and in peak workload, from 143.3 +/- 60.6 W to 158.6 +/- 67.5 W (p < 0.05). Improvement in anthropometry and body composition was observed but yielded no statistical significance. Most (80%) participants completed the three times/per week telesupervising exercise session for 12 weeks.No adverse event was identified.ConclusionFindings from this study suggest that home-based CORE may provide hematological cancer survivors with an increase in CRF during the rehabilitation period after hospital discharge. The telerehabilitation CORE model is effective, feasible, safe, and has demonstrated good adherence. Further randomized controlled efficacy study with larger sample size is needed before clinical implementation.